# Propranolol

## Pushingon oral solution 2mg/mL, 60mL(專案製造)

##### 臨採

| TAH Drug Code      | [LPUS](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LPUS)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | 本品無藥品許可證,依據「兒童困難取得之臨床必要藥品及醫材調度中心」計畫,食藥署同意專案製造。 Infantile hemangioma. Acute myocardial infarction, Reduction of cardiovascular mortality after myocardial infarction. Angina pectoris, chronic. Cardiac dysrhythmia. Essential tremor. Hypertension. Idiopathic hypertrophic subaortic stenosis. Migraine; Prophylaxis. Pheochromocytoma; Adjunct.                                                                                                                                                               |
| Dosing             | [Micromedex] Infantile hemangioma: (FDA dosage) Initial: 0.6 mg/kg orally twice daily given at least 9 hours apart beginning at 5 weeks to 5 months of age; after 1 week, increase to 1.1 mg/kg twice daily for 2 weeks then begin the maintenance dose. Maintenance: 1.7 mg/kg orally twice daily for 6 months; adjust periodically per weight increases. (Guideline dosage) 2 to 3 mg/kg/day orally unless there are comorbidities (eg, PHACE syndrome [disease characterized by congenital anomalies]) or adverse effects that necessitates lower doses. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity to propranolol hydrochloride or any component of the product. Pheochromocytoma. Blood pressure <50/30 mmHg, Heart rate <80 beats/min History of bronchial asthma or bronchospasm. Cardiogenic shock, Decompensated heart failure, Second or third degree heart block (if no pacemaker is present), Sick sinus syndrome (if no pacemaker is present), Sinus bradycardia (if no pacemaker is present). Premature infants with corrected age <5 weeks. Infants weighing <2 kg.                                                                |
| Adverse Effects    | Common: Diarrhea, Vomiting, Dizziness (Hypertension, 4-7%), Sleep disorder, Fatigue (5-7%) Serious: Bradyarrhythmia, Cardiogenic shock, Congestive heart failure, Heart block, Heart failure, Hypotension, Prolonged PR interval, Shortened QT interval, Erythroderma, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Hypoglycemia, Anaphylaxis, Cerebrovascular accident, Bronchospasm, Withdrawal symptom                                                                                                                                          |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/propranolol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

## Pronolol 10mg

| TAH Drug Code      | [OCAR1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCAR1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Angina, arrhythmias (ventricular and supraventricular), primary and renal hypertension, migraine, essential tremor, anxiety-induced tachycardia, adjunct in hyperthyroidism, pheochromocytoma.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | [Adult dosage] Angina pectoris: Initially 10-20 mg TID-QID, may titrate every 3-7 days gradually to 320 mg/day. Arrhythmia: 10-30mg TID-QID. Migraine prophylaxis: Initially 20mg QID; then up to 160-240 mg/day in divided doses. Hypertension: 120-240 mg/day, may increase to 640mg based on response and tolerability. Thyrotoxicosis: 10-40mg TID-QID. Pheochromocytoma: 20 mg before surgery, TID for 3 days, should be used in conjunction with an alpha-blocker. (Do not start using propranolol before the alpha-blocker has taken effect.) [Pediatric dosage] not yet established. Supraventricular tachycardia: 0.5 to 1 mg/kg/day in 3-4 divided doses. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | History of bronchial asthma or bronchospasm, Cardiogenic shock, Decompensated heart failure, Second or third degree heart block (if no pacemaker is present), Sick sinus syndrome (if no pacemaker is present), Sinus bradycardia (if no pacemaker is present) [Micromdex] Blood pressure <50/30 mmHg, Hypersensitivity to propranolol hydrochloride or any component of the product, Pheochromocytoma, Premature infants with corrected age <5 weeks, Infants weighing <2 kg                                                                                                                                                                                       |
| Adverse Effects    | Common: Diarrhea, Vomiting, Dizziness (Hypertension, 4-7% ), Sleep disorder, Fatigue (5-7% ) Serious: Bradyarrhythmia, Cardiogenic shock, Congestive heart failure, Heart block, Heart failure, Hypotension, Prolonged PR interval, Shortened QT interval, Erythroderma, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Hypoglycemia, Anaphylaxis, Cerebrovascular accident, Bronchospasm, Withdrawal symptom                                                                                                                                                                                                                                                |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/propranolol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

